Alginate Dressings Market

Rising Prevalence of Chronic Ulcers across the Globe Are Driving Demand for the Alginate Dressings Market

Alginate Dressings Market by type (Antimicrobial Alginate Dressings, Non Antimicrobial Alginate Dressings)

Industry: Healthcare

Published Date: February-2023

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 247

Report Price

$ 4900*

Buy Now
Request Report Sample

Report ID: PMRREP26929

Alginate Dressings Market Outlook (2023 to 2033)

The global revenue from the Alginate Dressings Market was around US$ 850.9 Million in 2022, with the global market expected to grow at a CAGR of 3.8% to reach a valuation of around US$ 1.27 Billion by the end of 2033.

Market Size (2023)

US$ 881.4 Million

Projected Market Value (2033)

US$ 1.27 Billion

Global Market Growth Rate (2023 to 2033)

3.8% CAGR

Market Share of Top 5 Countries

61.9%

As assessed by Persistence Market Research, antimicrobial dressings held a market share of around 72.2% in the global market, in 2022. Overall, alginate dressings market sales account for around 60.8% of revenue share in the global advanced wound dressing market, which was valued at around US$ 1.4 Billion in 2022.

Sales Analysis of Market from 2015 to 2022 Vs Market Outlook for 2023 to 2033

The global market recorded a historic CAGR of 3.0% in the last 7 years between 2015 and 2022.

Alginate dressings are cutting-edge materials for dressing wounds that can absorb liquids up to 15-20 times their own weight. Alginate dressings essentially keep the surroundings physiologically moist and reduce bacterial infections. There are many different types of alginate dressings, including hydrogels, foams, films, membranes, nanofibers, sponges, etc.

Anti-microbial alginate dressing and non-antimicrobial alginate dressing are the two main categories of alginate dressing products. The fundamental items designed to treat non-severe and acute wounds. These items are typically used to absorb exudate, stop bleeding, for closure of open surgical and trauma wounds, dry the wound, and promote faster wound healing.

It is anticipated that the market for alginate dressings would expand over the course of the assessment period due to the rising number of chronic wounds and burn cases around the world. Chronic wounds require a specialized management because they are one of the leading causes of morbidity and mortality, such as alginate dressings.

Major public health hazards are being brought on by an increase in burn incidents worldwide. The WHO in 2018, estimated that more than 180,000 individuals lost their lives to burns every year. As a result, the market for alginate dressings is anticipated to grow in the next years due to the increased demand for better wound dressing options for the treatment of burn ulcers.

The global market is likely to show high growth over the coming years at a CAGR of 3.8% and reach a global market size of US$ 1.27 Billion by 2033.

How Can the Global Market Grow?

Growing Demand for Complex Wound Treatment to Support Market Expansion

Traditional first-aid products have a number of disadvantages, including poor absorption of wound secretions, difficulty in maintaining a humid environment, poor gas exchange between the environment and the wound, due to allergies and non-sterile reactions, and difficulty in removing wound dressings once the wound has fully recovered. These products are frequently used in hospitals and homecare facilities for wound dressings.

Although traditional first-aid supplies continue to be in demand, sophisticated wound dressings are now more popular for the management and treatment of chronic wounds. The market for alginate dressings is expected to grow because of the special qualities of alginate dressings, which include a larger capacity for absorbing wound exudates, a reduction in bacterial infection, and an improvement in wound healing.

The main driver of the market for alginate dressings is anticipated to be the increase in the number of individuals over 65 in the world. The U.S. Census Board in 2018, estimates that 13% of the population is over 65 years old, and that number is predicted to rise to 20% by 2030.

Can the Market Growth Be Affected in Any Way?

Reluctance to Adopt New Technologies

Health care providers and physicians in Europe and Asia are reluctant to adopt Alginate Dressings technologies. It has also been observed that the adoption rate of Alginate Dressings products in Europe is low as compared to the U.S. High cost of Alginate Dressings therapy has been the essential factor for the reluctance of the physicians to adopt these technologies.

There are various bioengineered skin products available in the market; however, if cost analysis of these products is considered, then a normal dressing costs around US$ 3.25, whereas the bioengineered skin product costs around US$ 650. Due to the significant difference in costs, patients and health care providers are reluctant to adopt Alginate Dressings products. This results in stagnant sale of novel technologies, especially those without much advertisement or public knowledge.

Country-wise Insights

Why is the U.S. Market Booming?

“Increasing Prevalence of Diabetes”

The U.S. accounted for around 93.6% market share in the North America market in 2022. The dominance of the region can be linked to the rising incidence of chronic wounds, increased costs of treatment, and the existence of suitable insurance mechanisms in the region. According to the data published in StatPearls Publishing; 2022, more hospitalizations result from diabetic foot ulcers than from any other type of diabetic complication. In the US, diabetes is currently the main reason for non-traumatic amputations. In general, 5% of diabetes mellitus patients experience foot ulcers, and 1% require an operation.

The region is contributing to the worldwide industry's dominance by meeting the growing need for cutting-edge wound care products like alginate dressings due to the vast patient population suffering from chronic wounds.

Will the Germany Be a Lucrative Market for Alginate Dressings?

“Increasing Prevalence of Leg Ulcer Infection”

The Germany held around 9.9% market share in the global market in 2022. Increasing patients with chronic wounds is the factor responsible for regional dominance. For instance, according to “Prevalence and risk factors of chronic wounds in nursing homes in Germany: A Cross-Sectional Study. Int Wound J. 2020 Oct”, around 9.0% of men and 7.5% of women reported having chronic wounds, a little higher percentage than that of women. Chronic wounds affected 7.8% of all residents in total. 50.5% of people who had a chronic wound also had a pressure ulcer. Male residents experienced diabetic foot ulcers twice as frequently as female patients.

How is India Emerging as a Prominent Market?

“Increasing Medical Tourism”

India held a market share of about 49.5% of the South Asia market in 2022. The region's steady growth presents numerous prospects for the launch of new products. Additionally, the region is seeing an increase in medical tourism, which is leading to an increase in procedures. For instance, according to a report by the Indian Institute of Public Administration, around 697,453 foreign tourists travelled to India in 2019 to receive medical care.

The market in this region is also growing as a result of greater government support. Advanced wound care management has, however, been severely constrained in its growth by price sensitivity and ignorance.

Category-wise Insights

Which Dressing is Driving Demand within the Global Market?

“Effectiveness and Growing Advantages of Antimicrobial Dressing”

The antimicrobial alginate dressing segment held around 72.2% share of the total market in 2022. Antibacterial dressings are applied topically to the wound, where they provide a wide range of non-selective antibacterial effects.

Antimicrobial alginate-based wound dressings are available in a variety of forms, including hydrogels, coatings, foams, nanofibers, membranes, and sponges. Alginate dressings that fight germs absorb wound fluid to form gels that keep the wound site physiologically moist. Numerous researchers have discovered the efficacy of these wound coverings.

Which Indication is Widely in Focus in the Global Market?

“Growing Prevalence of Diabetes”

Chronic ulcers hold a share of about 64.0% in 2022, globally. Growing rates of diabetes and diabetic foot ulcers are a significant factor in the segment's expansion. For instance, in 2022, the Centre for Disease Control and Prevention, National Diabetes Statistics Report found that 37.3 million Americans, or 11.2% of the population, had diabetes.

The CDC projected that more than 96 million Americans over the age of 18 will have prediabetes in 2022. In addition, a similar source estimated that 26.4 million persons aged over 65 and above had prediabetes. Alginate wound dressings would help these ulcers heal as the number of people with diabetes increases.

Which Distribution Channel Propels the Global Sales?

“Growth in Surgical Procedures”

The institutional sales held a share of about 71.4% in 2022, within the global market. The prevalence of this segment can be attributed to both a rise in the number of patients and hospitals around the world.

The market is progressing due to a growth in surgical procedures. The latest recent figures available from a study report “Surgical activity in England and Wales during the COVID-19 pandemic: a nationwide observational cohort study. 2021”, show that 31, 02,674 surgical procedures were carried out in England and Wales in 2020. Alginate dressings are frequently used to cover surgical wounds, therefore as the frequency of procedures rises, so will their usage.

Competition Landscape

The prevalence of chronic conditions is predicted to increase, and alginate dressing products are expected to be more widely used than traditional injury dressing products over the course of the projection period. The quick market expansion is also brought on by manufacturers' ongoing attention on improving the functionality of alginate dressing solutions.

Some key instances of development include:

  • Delta Care Rx introduced a virtual service for wound care consulting in January 2021, pairing hospice and palliative care nurses with a doctor and nurse specializing in wound care.
  • GEMCO Medical introduced the GEMCORE360 brand of alginate dressings, which comprises foams, alginates, hydrocolloids, and thin film dressings, in 2019.

Similarly, the team at Persistence Market Research has tracked recent developments related to companies in the alginate dressings market, which are available in the full report.

Alginate Dressings Industry Report Scope

Attribute

Details

Forecast Period

2023 to 2033

Historical Data Available for

2015 to 2022

Market Analysis

USD Million for Value

Key Countries Covered

  • United States
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • BENELUX
  • Nordics Countries
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Türkiye
  • GCC Countries
  • North Africa
  • South Africa

Key Market Segments Covered

  • Alginate Dressing
  • Indication
  • Distribution Channel
  • Region

Key Companies Covered

  • 3M Company
  • Smith & Nephew Plc
  • ConvaTec Group Plc
  • Coloplast A/S
  • BSN medical GmbH
  • B. Braun Melsungen AG
  • Mölnlycke Health Care

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments Covered in Alginate Dressings Industry Research

Alginate Dressing:

  • Antimicrobial Alginate Dressings
  • Non Antimicrobial Alginate Dressings

Indication:

  • Chronic Ulcers
    • Venous Leg Ulcers
    • Diabetic Foot Ulcers
    • Pressure Ulcers
  • Non-Healing Surgical Wounds
    • Traumatic Wounds
    • Burn Cases

Distribution Channel:

  • Institutional Sales
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Long Term Care Centers
  • Retail Sales
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Sales

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

  • 3M Company
  • Smith & Nephew Plc
  • ConvaTec Group Plc
  • Coloplast A/S
  • BSN medical GmbH
  • B. Braun Melsungen AG
  • Mölnlycke Health Care

Frequently Asked Questions

The global market is currently valued at around US$ 850.9 Million in 2022.

The global market is set to reach a valuation of  US$ 881.4 Million by the end of 2023.

Sales of the market are set to witness growth at a CAGR of 3.8% and be valued at around US$ 1.27 Billion by 2033.

Demand for the global market increased at a 3.0% CAGR from 2015 to 2022.

The U.S., Germany, India, the U.K., and Russia account for most demand within the market, currently holding around 61.9% market share.

The U.S. accounts for around 93.6% share of the North American market in 2022.

India held a market share of about 49.5% of the South Asia market in 2022.

The Germany held around 9.9% market share in the global market in 2022.

3M Company, Smith & Nephew Plc, ConvaTec Group Plc, Coloplast A/S, BSN medical GmbH, B. Braun Melsungen AG and Mölnlycke Health Care are the key players active within this market space.

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate